| 000 | 01571 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517083111.0 | ||
| 264 | 0 | _c20161228 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1791-3004 | ||
| 024 | 7 |
_a10.3892/mmr.2016.4937 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQuan, Lin | |
| 245 | 0 | 0 |
_aTreatment with olopatadine and naphazoline hydrochloride reduces allergic conjunctivitis in mice through alterations in inflammation, NGF and VEGF. _h[electronic resource] |
| 260 |
_bMolecular medicine reports _cApr 2016 |
||
| 300 |
_a3319-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aConjunctivitis, Allergic _xdrug therapy |
| 650 | 0 | 4 |
_aCytokines _xanalysis |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xanalysis |
| 650 | 0 | 4 |
_aHistamine _xtoxicity |
| 650 | 0 | 4 |
_aImmunoglobulin E _xanalysis |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aNaphazoline _xtherapeutic use |
| 650 | 0 | 4 |
_aNerve Growth Factor _xanalysis |
| 650 | 0 | 4 |
_aOlopatadine Hydrochloride _xtherapeutic use |
| 650 | 0 | 4 |
_aOvalbumin _ximmunology |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xmetabolism |
| 700 | 1 | _aHe, Hua | |
| 773 | 0 |
_tMolecular medicine reports _gvol. 13 _gno. 4 _gp. 3319-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/mmr.2016.4937 _zAvailable from publisher's website |
| 999 |
_c25789795 _d25789795 |
||